Glomerular Diameter Is Associated with Reduction in Urinary Protein during Treatment with Dapagliflozin, a SGLT2 Inhibitor, in Patients with CKD

Authors: Hiroaki Komatsu, Arata Osanami, Keitaro Nishizawa, Masato Furuhashi

Published: 2024-10-28

DOI: 10.1681/asn.2024ntdg9gdt

Keywords: No keywords found.

Abstract:
No abstract found.

Source: